BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Kato T, Komori A, Bae SK, Migita K, Ito M, Motoyoshi Y, Abiru S, Ishibashi H. Concurrent systemic AA amyloidosis can discriminate primary sclerosing cholangitis from IgG4-associated cholangitis. World J Gastroenterol 2012; 18(2): 192-196 [PMID: 22253527 DOI: 10.3748/wjg.v18.i2.192]
URL: https://www.wjgnet.com/1007-9327/full/v18/i2/192.htm
Number Citing Articles
1
Emmanuel I. González-Moreno, Carlos R. Cámara-Lemarroy, David O. Borjas-Almaguer, Sylvia A. Martínez-Cabriales, Jonathan Paz-Delgadillo, Rodrigo Gutiérrez-Udave, Ana S. Ayala-Cortés, Jorge Ocampo-Candiani, Carlos A. Cortéz-Hernández, Héctor J. Maldonado-Garza. Cutaneous amyloidosis associated with autoimmune hepatitis-primary biliary cirrhosis overlap syndromeAnnals of Hepatology 2015; 14(3): 416 doi: 10.1016/S1665-2681(19)31283-9
2
Sophie Restellini, Olivier Chazouillères, Jean‐Louis Frossard. Hepatic manifestations of inflammatory bowel diseasesLiver International 2017; 37(4): 475 doi: 10.1111/liv.13265
3
Kwang Il Seo, Sang-Bum Kang. Hepatobiliary Manifestation of Inflammatory Bowel DiseaseThe Korean Journal of Gastroenterology 2019; 73(5): 248 doi: 10.4166/kjg.2019.73.5.248
4
Roberta E. Rossi, Dario Conte, Sara Massironi. Primary sclerosing cholangitis associated with inflammatory bowel diseaseEuropean Journal of Gastroenterology & Hepatology 2016; 28(2): 123 doi: 10.1097/MEG.0000000000000532
5
Rui Gaspar, Catarina Castelo Branco, Guilherme Macedo. Liver manifestations and complications in inflammatory bowel disease: A reviewWorld Journal of Hepatology 2021; 13(12): 1956-1967 doi: 10.4254/wjh.v13.i12.1956